IDH1 and melanoma: Although low-grade gliomas exhibited an overall decrease of PDL1 expression, about 20-30% of low-grade gliomas (with verified IDH1-R132 single allele mutation) demonstrated PDL1 values exceeding the average PDL1 level in melanomas (Figure 1A).